Same-Day versus Next-Day Dexamethasone Intracanalicular Insert Administration for Inflammation and Pain Control Following Cataract Surgery: A Retrospective Analysis

BACKGROUND: The dexamethasone 0.4mg intracanalicular insert (Dextenza, Ocular Therapeutix, Bedford, MA) is approved for control of postoperative pain and inflammation following ocular surgery. This study compared pain and inflammation resolution following phacoemulsification in eyes that received th...

Descripción completa

Detalles Bibliográficos
Autor principal: Foster, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541700/
https://www.ncbi.nlm.nih.gov/pubmed/34703199
http://dx.doi.org/10.2147/OPTH.S335764

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8541700/
https://www.ncbi.nlm.nih.gov/pubmed/34703199
http://dx.doi.org/10.2147/OPTH.S335764

Ejemplares similares